These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 454965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of quipazine on blood pressure in pithed rats.
    Shin YK, Svinareff P, Schmitt-Jubeau H, Schmitt H.
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats.
    Alper RH, Snider JM.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):829-33. PubMed ID: 3320345
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A, Antkiewicz-Michaluk L, Vetulani J.
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives].
    Trubitsyna TK, Asnina VV, Mashkovskiĭ MD.
    Farmakol Toksikol; 1986 Mar; 49(1):44-9. PubMed ID: 3948987
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quipazine-induced stimulus control in the rat.
    Winter JC.
    Psychopharmacology (Berl); 1979 Feb 28; 60(3):265-9. PubMed ID: 108704
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
    Sanders-Bush E, Breeding M.
    J Pharmacol Exp Ther; 1990 Mar 28; 252(3):984-8. PubMed ID: 2319481
    [Abstract] [Full Text] [Related]

  • 14. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
    Jacoby JH, Poulakos JJ.
    J Pharm Pharmacol; 1977 Dec 28; 29(12):771-3. PubMed ID: 22629
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A serotonin agonist-antagonist reversible effect on Na+-K+-ATPase activity in the developing rat brain.
    Hernández RJ.
    Dev Neurosci; 1982 Dec 28; 5(4):326-31. PubMed ID: 6291893
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sleep suppressant action of quipazine: relation to central serotonergic stimulation.
    Fornal C, Radulovacki M.
    Pharmacol Biochem Behav; 1981 Dec 28; 15(6):937-44. PubMed ID: 7323120
    [Abstract] [Full Text] [Related]

  • 19. Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex.
    Lucki I, Minugh-Purvis N.
    Brain Res; 1987 Sep 15; 420(2):403-6. PubMed ID: 2960422
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.